T-cell Prolymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for T-cell Prolymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma [Phase 2]
An ongoing Phase 2 study evaluating maintenance therapy with ruxolitinib after hematopoietic stem cell transplant in patients with T-cell ly…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study of Ruxolitinib and Duvelisib in People With Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating the combination of ruxolitinib and duvelisib in patients with T-cell and NK-cell lymphomas is currently …
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia [Phase 1, Phase 2]
This clinical trials entry describes a Phase Ib/II study evaluating a triplet regimen of cladribine, ruxolitinib, and venetoclax in relapsed…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Observatory of Prolymphocytic Leukemia T
This is a clinical trial registry entry for an ongoing study on prolymphocytic leukemia of T-cell origin, with recruitment currently ongoing…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL [Phase 2]
A Phase 2 clinical trial update indicates Ascentage Pharma is evaluating APG-115 alone or with APG-2575 in relapsed/refractory T-cell prolym…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients [Phase 1]
Phase 1 trial evaluating Itacitinib with high-dose posttransplantation cyclophosphamide in older patients. The study is currently ACTIVE_NOT…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of duvelisib and venetoclax in relapsed or refractory peripheral T-cell lymphoma, w…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating sequential CD5/CD7-specific CAR-T cells for CD5/CD7-positive T-cell malignancies including T-…